As of June 21, 2025, Myovant Sciences Ltd (MYOV) reports a Graham Number of N/A.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Comparing Myovant Sciences Ltd's Graham Number to Peers
To better understand Myovant Sciences Ltd's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Myovant Sciences Ltd (MYOV) | - |
| Krystal Biotech Inc (KRYS) | 47.68 |
| Cullinan Oncology Inc (CGEM) | 27.05 |
| Centessa Pharmaceuticals PLC (CNTA) | 21.83 |
| Zymeworks Inc (ZYME) | 16.78 |
| Arcus Biosciences Inc (RCUS) | 13.81 |
Compared to its competitors, Myovant Sciences Ltd's Graham Number is difficult to compare due to insufficient data.